SCHEMBL26073652

SCHEMBL26073652

Cc1c(-c2cccc3c2-c2ccccc2C3)cccc1-c1cccc2sc3ccccc3c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K9 P80192 2/20 0.41
MAP3K11 Q16584 2/20 0.41
BRDT Q58F21 1/20 0.36
GPR3 P46089 1/20 0.34
POLB P06746 3/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
DUSP3 P51452 1/20 0.33
BLM P54132 1/20 0.33
PTPN5 P54829 1/20 0.33
PTPN11 Q06124 1/20 0.33
MCL1 Q07820 1/20 0.33
CTDSP1 Q9GZU7 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
DRD2 P14416 1/20 0.32
DRD1 P21728 1/20 0.32
DRD4 P21917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25456509 0.86 MAP3K9 (0.39) MAP3K9MAP3K11BRDTGPR3POLB
SCHEMBL26073646 0.84 GPR3 (0.48) BRDTGPR3POLBMEN1MAPT
SCHEMBL17954609 0.80 MAP3K9 (0.46) MAP3K9MAP3K11BRDTGPR3POLB
SCHEMBL29177781 0.77 MAP3K9 (0.46) MAP3K9MAP3K11BRDTGPR3POLB
SCHEMBL21742607 0.77 PDCD1 (0.45) BRDTGPR3POLBMEN1MAPT
SCHEMBL26073631 0.77 NQO1 (0.34) POLBMEN1MAPTKMT2AALDH1A1
SCHEMBL27388014 0.76 GPR3 (0.43) BRDTGPR3POLBMEN1MAPT
SCHEMBL26270506 0.76 BRDT (0.38) BRDTGPR3POLBMEN1MAPT
SCHEMBL30022365 0.76 MAP3K9 (0.38) MAP3K9MAP3K11BRDTPOLBMEN1
SCHEMBL30550557 0.75 GPR3 (0.59) BRDTGPR3POLBMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303602-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303602-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ODC1 MAP3K9 4229/4885MAP3K11 4413/4885BRDT 691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.